Winner Medical(SZ:300888) Xin Lang Zheng Quan·2026-01-29 01:24Core Viewpoint - The financial performance and trading activity of Shengjian Medical indicate a mixed sentiment among investors, with notable fluctuations in financing and stockholder dynamics [1][2][3]. Group 1: Financial Performance - Shengjian Medical reported a revenue of 7.897 billion yuan for the period from January to September 2025, reflecting a year-on-year growth of 30.10% [2]. - The company's net profit attributable to shareholders reached 732 million yuan, marking a year-on-year increase of 32.36% [2]. - Cumulatively, the company has distributed 2.875 billion yuan in dividends since its A-share listing, with 1.729 billion yuan paid out in the last three years [3]. Group 2: Trading Activity - On January 28, Shengjian Medical's stock price fell by 1.41%, with a trading volume of 164 million yuan [1]. - The financing buy-in amount for the day was 16.99 million yuan, while the financing repayment was 18.75 million yuan, resulting in a net financing outflow of 1.76 million yuan [1]. - As of January 28, the total balance of margin trading for Shengjian Medical was 380 million yuan, with the financing balance accounting for 1.78% of the circulating market value, indicating a high level compared to the past year [1]. Group 3: Shareholder Dynamics - As of September 30, 2025, the number of shareholders for Shengjian Medical increased to 32,100, up by 15.06% from the previous period [2]. - The average number of circulating shares per shareholder rose to 18,048 shares, an increase of 186.92% compared to the last period [2]. - Among the top ten circulating shareholders, notable changes include a decrease in holdings by Huabao Zhongzheng Medical ETF and a slight increase by Hong Kong Central Clearing Limited [3].